BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang X, Xu W, Li M, Zhang P, Zhang YS, Ding J, Chen X. Antiviral biomaterials. Matter 2021;4:1892-918. [DOI: 10.1016/j.matt.2021.03.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Deng K, Li Y, Liang X, Shen C, Zeng Z, Xu X. Virus-inspired nanoparticles as versatile antibacterial carriers for antibiotic delivery against Gram-negative and Gram-positive bacteria. Chinese Chemical Letters 2022;33:1619-22. [DOI: 10.1016/j.cclet.2021.09.045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ahmadi V, Nie C, Mohammadifar E, Achazi K, Wedepohl S, Kerkhoff Y, Block S, Osterrieder K, Haag R. One-pot gram-scale synthesis of virucidal heparin-mimicking polymers as HSV-1 inhibitors. Chem Commun (Camb) 2021;57:11948-51. [PMID: 34671786 DOI: 10.1039/d1cc04703e] [Reference Citation Analysis]
3 Yeh JJ, Lai M, Lin CL, Lu KH, Kao CH. Effects of statins on the risks of ischemic stroke and heart disease in human immunodeficiency virus infection, influenza and severe acute respiratory syndrome-associated coronavirus: respiratory virus infection with steroid use. Postgrad Med 2022. [PMID: 35590450 DOI: 10.1080/00325481.2022.2080359] [Reference Citation Analysis]
4 Wang F, Ma M, Cao H, Chai X, Huang M, Liu L. Conjugated polymer materials for detection and discrimination of pathogenic microorganisms: Guarantee of biosafety. Biosafety and Health 2022. [DOI: 10.1016/j.bsheal.2022.03.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang X, Chen X, Zhao Y. Nanosystems for Immune Regulation against Bacterial Infections: A Review. ACS Appl Nano Mater . [DOI: 10.1021/acsanm.2c01380] [Reference Citation Analysis]
6 Han Y, Pan J, Ma Y, Zhou D, Xu W. Protein-based biomaterials for combating viral infections: current status and future prospects for development. Biosafety and Health 2022. [DOI: 10.1016/j.bsheal.2022.03.005] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Morajkar RV, Kumar AS, Kunkalekar RK, Vernekar AA. Advances in nanotechnology application in biosafety materials: a crucial response to COVID-19 pandemic. Biosaf Health 2022. [PMID: 35765656 DOI: 10.1016/j.bsheal.2022.06.001] [Reference Citation Analysis]
8 Ding J, Xiao H, Chen X. Advanced biosafety materials for prevention and theranostics of biosafety issues. Biosafety and Health 2022. [DOI: 10.1016/j.bsheal.2022.03.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wang L, Wang Z, Cao L, Ge K. Constructive strategies for drug delivery systems in antivirus disease therapy by safety materials. Biosafety and Health 2022. [DOI: 10.1016/j.bsheal.2022.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]